Very nicely analysis on Nandan Denim. The company looks really promising and attractively priced. Just one thing which I wish to have clarity is to by knowledge there is no excise duty currently levied on textile. If GST comes then automatically textile industry would come under taxation. How would GST affect Nandan & industry on the whole.
Posts tagged Value Pickr
ALLSEC Technology – BPO turnaround story (15-12-2015)
Check the segment-wise results...
Sarla Performance Fibres – Another Interesting Textile Story in Making? (15-12-2015)
Hi Aravind, How do u know HDFC and IDFC are picking sarla? please share your source of info?
Hitesh portfolio (15-12-2015)
Hi Hitesh,
Sorry that i am asking a very basic question. (@admins, you can delete or point to any section. i already read the pharma faq.) Could you tell the difference between generics and branded generics?. My understating was that, once a drug goes off patent, generic players will produce generic version of the same. different companies market with different names. is that the brand?. or is it the name used by the innovator?
are there any branded generic players in india?
Companies affected by Chennai Flood? (15-12-2015)
I think stocks like Shriram Transport, South Indian Bank, Chola Investment would be affected due to likely increase in NPA. Tube Investment could be affected as they have major operations in Chennai area.
Ranvir’s Portfolio (15-12-2015)
@ angad....no...it was only a rough guess....actually I dont live in a metro....can u throw some light on the kind of rentals they would be paying....i would love to have a better idea of the same.
Sarla Performance Fibres – Another Interesting Textile Story in Making? (15-12-2015)
They are in the process of being picked up by MF's like HDFC and IDFC, so once that happens they come into the open, get out there before they are known. The US business has great future. Nike and others order Nylon 66 from these fellows. Most importantly they have already done Capex, now just need to milk it.
Nandan Denim Limited – No. 1 position in denim play (15-12-2015)
Thanks for wonderfull writeup.
Ranvir’s Portfolio (15-12-2015)
Do you have a basis for the high level calculation? For instance none of the starbucks outlets look like they have a rental of only 4lacs/month.
Hitesh portfolio (15-12-2015)
advait,
The pharma market in India is highly fragmented. Most of the companies we discuss have a presence in most of the lifestyle segments. e.g Lupin, Torrent pharma, ajanta, sun, u name it and most of them have good presence in life style segments. But as you can make out companies having only domestic presence will have a tough time due to intense competition.
The most attractive facet of pharma companies from India are their US revenues and profits. Among these one has to look at companies with presence in niche segments/complex molecules etc where competition is likely to be low.
The important criteria for listing down US facing pharma companies are:
Pipeline of filings/approvals.
Existing base business and how good that is.
Track record of company with regulatory authority (USFDA)
Management smarts --- how well does the company utilise the opportunity available.
And one has to bear in mind the fact that with companies deriving major part of their revenues from US, two main risks are those of USFDA regulatory risk and currency risk. (Small 1-2 rupee moves in currency dont matter much but a big swing of 10% or more would materially impact quantum of profits)
Ideal company could be a company which has a stable business model which gives it predictability and which is just climbing the ladder in the US. e.g Ajanta. But there again one has to be comfortable with valuations bcos very few pharma companies are available cheap now.
And if one is not too clear about the whole thing then it makes sense to buy a basket of pharma stocks and hope for the best.